Changes in synovial fluid and serum cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I over five years after anterior cruciate ligament rupture: An exploratory analysis in the KANON trial.

André Struglics; Staffan Larsson; Nobuyuki Kumahashi; Richard Frobell; Stefan Lohmander

doi:10.1002/art.39146

Changes in synovial fluid and serum cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I over five years after anterior cruciate ligament rupture: An exploratory analysis in the KANON trial.

André Struglics, Staffan Larsson, Nobuyuki Kumahashi, Richard Frobell, Stefan Lohmander

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Sammanfattning

Prospectively monitor levels of synovial fluid and serum pro-inflammatory cytokines and aggrecan ARGS neoepitope, and urine C-terminal type II (CTX-II) and N-terminal type I (NTX-I) collagen cross-linked telopeptides after acute anterior cruciate ligament (ACL) rupture.

Originalspråk	engelska
Sidor (från-till)	1816-1825
Tidskrift	Arthritis & Rheumatology
Volym	67
Nummer	7
DOI	https://doi.org/10.1002/art.39146
Status	Published - 2015

Ämnesklassifikation (UKÄ)

Reumatologi och inflammation

Tillgång till dokument

10.1002/art.39146

http://www.ncbi.nlm.nih.gov/pubmed/25914389?dopt=Abstract

Fingeravtryck

Utforska forskningsämnen för ”Changes in synovial fluid and serum cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I over five years after anterior cruciate ligament rupture: An exploratory analysis in the KANON trial.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här

@article{cd904957ea3b49a4845e41cd7e39d6e3,

title = "Changes in synovial fluid and serum cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I over five years after anterior cruciate ligament rupture: An exploratory analysis in the KANON trial.",

abstract = "Prospectively monitor levels of synovial fluid and serum pro-inflammatory cytokines and aggrecan ARGS neoepitope, and urine C-terminal type II (CTX-II) and N-terminal type I (NTX-I) collagen cross-linked telopeptides after acute anterior cruciate ligament (ACL) rupture.",

author = "Andr{\'e} Struglics and Staffan Larsson and Nobuyuki Kumahashi and Richard Frobell and Stefan Lohmander",

year = "2015",

doi = "10.1002/art.39146",

language = "English",

volume = "67",

pages = "1816--1825",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "John Wiley & Sons Inc.",

number = "7",

}

Changes in synovial fluid and serum cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I over five years after anterior cruciate ligament rupture: An exploratory analysis in the KANON trial. / Struglics, André ; Larsson, Staffan; Kumahashi, Nobuyuki et al.

I: Arthritis & Rheumatology, Vol. 67, Nr. 7, 2015, s. 1816-1825.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

TY - JOUR

T1 - Changes in synovial fluid and serum cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I over five years after anterior cruciate ligament rupture: An exploratory analysis in the KANON trial.

AU - Struglics, André

AU - Larsson, Staffan

AU - Kumahashi, Nobuyuki

AU - Frobell, Richard

AU - Lohmander, Stefan

PY - 2015

Y1 - 2015

N2 - Prospectively monitor levels of synovial fluid and serum pro-inflammatory cytokines and aggrecan ARGS neoepitope, and urine C-terminal type II (CTX-II) and N-terminal type I (NTX-I) collagen cross-linked telopeptides after acute anterior cruciate ligament (ACL) rupture.

AB - Prospectively monitor levels of synovial fluid and serum pro-inflammatory cytokines and aggrecan ARGS neoepitope, and urine C-terminal type II (CTX-II) and N-terminal type I (NTX-I) collagen cross-linked telopeptides after acute anterior cruciate ligament (ACL) rupture.

U2 - 10.1002/art.39146

DO - 10.1002/art.39146

M3 - Article

C2 - 25914389

SN - 2326-5205

VL - 67

SP - 1816

EP - 1825

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 7

ER -